Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

EyeControl: A Communication Solution for Ventilated ICU Patients and Locked-in Individuals

Project description

Wearable eye tracking device for Covid-19 patients

The spread of the deadly Covid-19 pandemic across the globe has put a worrying strain on critical care resources. The spike seen in some countries in the number of patients requiring admission to intensive care units necessitates constant communication between doctors and patients and their families. The EU-funded Eyecontrol project will develop an immediate and efficient assistive technology: the first wearable and screenless assistive communication device that secures easy and safe communication between patients, medical and care staff and families. The device is based on eye-tracking technology driven by artificial intelligence; it enables communication through eye movements, without requiring calibration or dependence on a screen or computer. The project will develop additional improvements to its technology, to facilitate entry into the medical facility market.

Objective

EyeFree Assisting Communication Ltd. developed the EyeControl, the first wearable, screenless assistive communication device. AI-powered eye-tracking technology enables communication between patients, medical staff and family, using only eye movements, without calibration or dependency on a screen or computer. EyeFree is changing reality, empowering autonomy among the Locked-in community by providing a round-the-clock communication solution that is operated independently by the user.

EyeFree is expanding the scope of the recently finalized SME Phase 2 grant with the aim of developing additional improvements to the EyeControl technology, which will expedite medical facility market entry strategy. Short-term demand in this segment is growing; where an unmet need for communication in the ICU already existed, it has been further exasperated by an influx of ventilation caused by the Coronavirus. There is no solution on the market; and, that places the EyeControl at the forefront, as an immediate and effective assistive technology, facilitating easy and safe communication between patients, medical staff, caregivers, and families and leading to better quality patient care. Once this niche market has been consolidated, we will boost the market entry be known as the global communication platform for both ventilated and Locked-in patients, with two main product lines: EyeControl Home and Facility.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-2 - SME instrument phase 2

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

EYEFREE ASSISTING COMMUNICATION LTD
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 2 134 658,75
Address
48 MENACHEM BEGIN SUITE 907
6618003 Tel Aviv Jaffa
Israel

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 3 049 512,50
My booklet 0 0